QUEBEC CITY, March 14, 2014 /PRNewswire/ -- As regulation agencies are enforcing measures against counterfeit products, Optel Vision is announcing a major investment to support the pharmaceutical manufacturing industries which are deeply involved in this critical fight.
After a $4M investment in 2012-2013 on corporate facility expansion, SAP-ERP implementation, Education Center and support teams across Europe and Asia, the next phase is expanding distribution resources in Europe, Americas and Asia.
With this expansion Optel Vision will see a growth of over 400 employees by 2016.
Optel Vision will invest $10M in the next 18 months increasing its deployment and support teams around the globe. The implementation of Track & Trace technologies on packaging lines requires specialized engineering services linked to unique hardware and software modules which is Optel Vision's strength.
The $10M reinvestment will be focused toward:
- Expanding its manufacturing and engineering operations in India.
- Establishing a European facility in Germany with local engineering, software support, factory acceptance test, and a spare parts warehouse.
- Significantly increase local deployments of project managers as well as field technicians in over 10 countries.
Optel Vision's automated inspection systems currently inspect millions of packages every day around the world. Optel Vision's commitment to innovation is driven by the requirements placed upon us by pharmaceutical and packaging industries.
For twenty-five years, hundreds of pharmaceutical companies around the globe have trusted Optel Vision to reduce packaging errors and ensure patient safety.
For more information visit: www.optelvision.com.
Ken Fallu, Marketing & Product Management Director
SOURCE Optel Vision